This is the twenty-fifth in a series of stories about a scientist named Edward Vitello who has in his possession a very, very powerful love potion developed in a secret government sponsored research project that, to his dismay, was cancelled. He is determined to continue the research by doing human trials on a wide variety of selected women.
The chemical is called SX69. It is an extract of Bonobo monkey DNA combined with a molecularly altered Oxytocin from the common shrew. Bonobo monkeys use constant sex as a social bonding tool and female shrew's mate for life after one whiff of a male's unique Oxytocin. The potion works exactly on human females as it had with animals in the lab.
Do read the previous installments which chronicle the use of SX69 from the first subject, a sweet young librarian name Sarah, who is still a happy member of Professor Vitello's harem of women in England. He also has a harem in Cambridge of brilliant women of science led by a world-renowned scientist named, Janette Frohlich, PhD. They love their life after being dosed with SX69 and are doing advanced research on it to make it available to other women.
There are many erotic twists and surprising turns along the way in the previous twenty-four installments. These include bringing a young man named Keith MacLean as a test subject to form his own harem of SX69 dosed women. Professor Vitello is his mentor and financier.
In this chapter, Dr. Frohlich and her team of female scientists have reformulated SX69 into a short-term libido enhancer for women, what the public calls, 'Viagra for Women.' The market for this drug would be enormous and the benefits to womankind are immense.
Edward and his protégé Keith are having the sex lives of sultans but always keeps in mind that they are conducting a serious human drug trial for the SX69 potion and any derivatives of it. Edward's motto is, "I have much work ahead of me combining science and pleasure."
The Search for "Viagra for Women"
My Name is Dr. Janette Frohlich. I am the lead scientist on project to design a short-term libido enhancer for women derived from powerful SX69 drug. We are now at the stage of testing this drug on women in the presence of a male surrogate. How will their sexual instincts be enhanced and how will they act out stronger sexual impulses with the male surrogate? What are any side effects?
The drug has been in a beta trial for dosage levels and safety for the last five months. This was done on female university student volunteers in a controlled laboratory setting. We started with extremely small dosages and raised them gradually. We check the subject's physical arousal levels such as skin sensitivity and vaginal moisture generation. We also monitored their erotic thought processes. Members of our team would ask questions of the subject at ten-minute intervals. When we went above the optimal dosage there were some incidents where the female test subjects would masturbate vigorously with any handy object or with their fingers if no suitable object was available. No injuries were reported. When we were confident that we had found the proper dosage levels, the Phase I trial was complete and we are now in Phase II.
Of course, we could not test the drug on unsuspecting women. This is the #MeToo age and besides, it is simply not ethical. The team went to great lengths to assemble a list of women who volunteered to be test subjects. An advertisement in a high-end woman's magazine had garnered hundreds of replies. It seems that many women are disappointed in their current sex lives and strive for change.
The list was distilled down to thirty names. Woman of various ages from twenty to forty were chosen from all walks of life. They were single and married, working and stay at home. Different religions and races were included. The ladies had to have at least a high school diploma, and many were university graduates. The participants were given a thorough health and fitness checkup. This was a great sample group.
The participants all signed a waiver agreeing to the experiment. They were told a male sexual surrogate would be present after they were given a libido enhancing drug. Any sexual activity would be strictly voluntary on their part. They filled out a sex history and added their goals for the future.
Specifics of test area: Sitting room with table and two chairs, large sofa and music system. Non-alcoholic beverages in a bar fridge. Door to bedroom with bed. Two-way mirror on entire wall for researchers to monitor the subjects. Four video cameras with audio to record everything.
Subject #2. Ms. W.
Age: 38 Height 5' 8" Weight 131.0 Lb. Measurements 38C-27-37 Divorced for seven years.
Profession: VP Finance, large public corporation.
Fitness: Twice a week in gym with trainer. Golf, once a week with no cart.
Sexual History:
Had first boyfriend as freshman in university. Casual relationship with minimal sex. Academic studies were focus. Relationship ended as both parties went back to their hometowns, far distance apart. Occasional alcohol assisted sexual affairs but nothing of a relationship until meeting husband at workplace. Divorced after two years. Husband complained of her workaholic habits. First six months of marriage experienced passionate sex but then a decline to very little. Since divorce seven years ago, sexual contact very infrequent one-night stands. One lesbian experience was not fulfilling. Hired male escorts three times while on various business trips, unfulfilling each time.
Current Sexual activity: Has not had sex for three years. Blames high stress job. Never masturbates.
Her objective for participating: Career goals have been reached and work-life balance is now possible and desired. Best friend in college recently died of breast cancer. Realizes that she is alone with no relationship or children. Wants to change that. Libido is dormant. Hopes treatment will kick-start her sex life.
The Session Notes of Dr. J. Frohlich:
From my and my team's observation posts in our lab next to the test room we will record our observations. Subject #2 will be a tough test since her sex drive is very dormant. It was decided that Keith MacLean would be the male surrogate rather than Dr. Vitello. He is younger and likely more desirable as a sexual partner for a female like Ms. W.
The subject is led into the room by Melissa Stewart PhD., a research team member. The room has soft lighting but excellent visibility for our scientific observations. Hidden cameras record everything. Soft music is playing.
Dr. Stewart: "Ms. W., let me go over the procedures. After I leave, the male surrogate will come in and introduce himself. Remember that you have complete freedom to refrain from any intimate activity with him. Simply proceed at your personal comfort level.
If, after meeting him, you wish to proceed, he will give you a sealed envelope in which there is gauze pad with the drug agent. Open the envelope and inhale fully the active ingredient. You should feel the effects almost immediately. Don't worry. It is very pleasurable and will dissipate in a few hours. From then on, proceed as you wish. After an interval of one to three hours, you will begin to feel sleepy. After you awake, the effects of the drug will be gone. Is that clear? Good.
I'll leave you now. The male surrogate will be in shortly."
Keith MacLean Observes the subject from behind the two-way glass.
Ms. W. is an attractive woman. From her profile I read she is a successful executive. She dresses the part with a pinstripe grey pantsuit and blouse with low heel brown leather, Oxford laced business shoes. One would expect a woman to wear more casual clothes to the session, but I expect Ms. W. only has business-wear or formal dresses.
